Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arginomycin: production, isolation, characterization and structure.

A D Argoudelis, L Baczynskyj, M T Kuo

    The Journal of Antibiotics
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer.

    Cell & developmental biology·2017
    Same author

    Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents.

    Oncogene·2015
    Same author

    Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.

    British journal of cancer·2012
    Same author

    Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.

    Current molecular medicine·2010
    Same author

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    British journal of cancer·2009
    Same author

    A new aspect on glutathione-associated biological function of MRP/GS-X pump and its gene expression.

    Cytotechnology·2008
    Same journal

    Macrolide antibiotic action, resistance, and tolerance, and approaches to improve their activity against Gram-negative bacteria.

    The Journal of antibiotics·2026
    Same journal

    Activation of hamiformamide production in the thermotolerant fungus Hamigera avellanea triggered by co-culture with animal immune cells.

    The Journal of antibiotics·2026
    Same journal

    Biosynthesis and enzymology of azaindane natural products.

    The Journal of antibiotics·2026
    Same journal

    Inhibition of Proteus mirabilis growth through gallium-based disruption of iron and heme metabolism.

    The Journal of antibiotics·2026
    Same journal

    Artificial intelligence-based phenotypic screening using Aspergillus oryzae identified a novel antifungal RK-1205-I.

    The Journal of antibiotics·2026
    Same journal

    Catenulamide A, an acylated tripeptide containing 5-methoxy-L-kynurenine lactam from an actinomycete of the genus Catenuloplanes.

    The Journal of antibiotics·2026
    See all related articles

    A novel nucleoside antibiotic, arginomycin, effectively inhibits Gram-positive bacteria and fungi growth. This compound, related to blasticidin S, shows low toxicity in preliminary assessments.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Natural Products Chemistry

    Background:

    • Streptomyces arginesis is a source of novel antimicrobial compounds.
    • Nucleoside antibiotics represent a significant class of therapeutic agents.
    • Blasticidin S is a known antibiotic with a related chemical structure.

    Purpose of the Study:

    • To introduce and characterize arginomycin, a newly discovered nucleoside antibiotic.
    • To evaluate the antimicrobial activity of arginomycin against pathogenic microorganisms.
    • To assess the preliminary toxicity profile of arginomycin.

    Main Methods:

    • Isolation and structural elucidation of arginomycin from Streptomyces arginesis.
    • In vitro antimicrobial susceptibility testing against Gram-positive bacteria and fungi.

    Related Experiment Videos

  • Preliminary toxicological evaluation of the compound.

    • Main Results:

    • Arginomycin was identified as a novel nucleoside antibiotic with the chemical formula C18H28N8O5.
    • The compound demonstrated significant inhibition against Gram-positive bacteria and fungi in vitro.
    • Arginomycin exhibited a relatively non-toxic profile in initial assessments.
    • Structural analysis revealed a relationship to blasticidin S.

    Conclusions:

    • Arginomycin is a promising new antibiotic agent with potential therapeutic applications.
    • Its activity against Gram-positive bacteria and fungi warrants further investigation.
    • The favorable toxicity profile suggests potential for development.